• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ethos Partners with Amanda Kloots to Help Families Take Control of the One Thing They Can

    7/14/26 9:05:00 AM ET
    $LIFE
    Specialty Insurers
    Finance
    Get the next $LIFE alert in real time by email

    AUSTIN, Texas, July 14, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced a new campaign partnership with Amanda Kloots, fitness entrepreneur, television host, and one of the most recognized voices on grief, resilience, and family in America. In a new national campaign, Kloots shares her own story to help families understand why life insurance matters and why, through Ethos, there is no reason to put it off.

    "Amanda's story is known to millions of people who watched her family go through the unimaginable in real time," said Prassath Leelakrishnan, Chief Growth Officer at Ethos. "What makes her the right partner for Ethos is not just the reach of that story, it's what she chose to do with it. She is speaking honestly about the practical reality of loss, about what helped and what didn't, and about why she wants other families to be prepared. That's exactly the conversation we want to start."

    When COVID-19 took the life of her husband in July 2020, Amanda Kloots spent 95 days documenting his fight from an ICU to millions of followers who had come to know and love their family. His death, and the outpouring that followed, made her one of the most visible faces of a generation's collective reckoning with mortality and the unexpected.

    According to the 2025 LIMRA Insurance Barometer Study, nearly 100 million1 American adults are either uninsured or underinsured when it comes to life insurance, a gap driven in part by the widespread belief that getting covered is complicated, time-consuming, or requires a medical exam. The Ethos platform was built to eliminate each of those barriers, offering a fully digital experience that requires no medical exam, no doctor visits, and just a few online health questions, enabling many applicants to get covered in minutes.

    Through her partnership with Ethos, Kloots will appear in a national television and digital campaign anchored by a thirty-second spot. The campaign "Because Life Goes On" follows Kloots speaking directly to camera about her husband's death, the stability life insurance provided her and her son, and the simplicity of getting covered through Ethos today.

    The Ethos and Amanda Kloots campaign will air nationally across television and digital platforms, reinforcing a shared commitment to helping families protect what matters most.

    About Ethos

    Ethos is a leading life insurance technology company on a mission to protect families by democratizing access to life insurance and empowering agents at scale. With its robust three-sided technology platform, Ethos is transforming the life insurance experience for consumers, agents, and carriers alike. Ethos offers instant, accessible products and a seamless online process that requires no medical exams and just a few health questions; it eliminates traditional barriers, making it easier than ever for everyone to protect their families. Through its platform, Ethos is redefining how life insurance is bought, sold, and underwritten. Learn more at ethos.com.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "project," "will," or similar expressions and include, but are not limited to, statements regarding the expected benefits of Ethos’ partnership with Amanda Kloots, including the anticipated synergy of the Ethos and Amanda Kloots campaign and Ethos’ platform, and any other statements that are not historical facts. These forward-looking statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including risks described in the "Risk Factors" section of Ethos' Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the Securities and Exchange Commission ("SEC") on May 8, 2026 and in other reports Ethos files from time to time with the SEC. Except as required by law, Ethos undertakes no obligation, and does not intend, to update these forward-looking statements.

    Media Contact:

    Allyson Savage

    Allyson.savage@ethos.com

    1 LIMRA and Life Happens 2025 Insurance Barometer Study



    Primary Logo

    Get the next $LIFE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LIFE

    DatePrice TargetRatingAnalyst
    2/23/2026$33.00Buy
    Goldman
    2/23/2026$18.00Outperform
    Robert W. Baird
    2/23/2026$21.00Mkt Outperform
    Citizens
    2/23/2026$20.00Overweight
    Barclays
    2/23/2026$23.00Buy
    Deutsche Bank
    2/23/2026$13.00Overweight
    Analyst
    2/23/2026$15.00Buy
    Citigroup
    2/23/2026Outperform
    William Blair
    More analyst ratings

    $LIFE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Botha Roelof bought $4,949,975 worth of shares (260,525 units at $19.00), converted options into 12,000,124 shares and returned 12,000,124 shares to the company (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    2/2/26 6:36:37 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Director Wheeler William J bought $4,949,975 worth of shares (260,525 units at $19.00), increasing direct ownership by 2,481% to 271,025 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    1/30/26 8:49:26 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Director Mullin Mark W. bought $99,997 worth of shares (5,263 units at $19.00), increasing direct ownership by 43% to 17,451 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    1/30/26 8:48:09 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children

    AUSTIN, Texas and DES MOINES, Iowa, July 21, 2026 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the expansion of its Accumulation Indexed Universal Life (IUL) product, issued by North American Company for Life and Health Insurance®, to include juvenile coverage. Parents can now apply for a standalone Accumulation IUL policy for their child — from infants to age 17 — entirely online, with no medical exams1 and a streamlined digital experience built by Ethos. Accumulation IUL offered to juveniles combines permanent life insurance protection with tax-advantaged cash value growth potential 2— giving

    7/21/26 9:07:00 AM ET
    $LIFE
    Specialty Insurers
    Finance

    Ethos Partners with Amanda Kloots to Help Families Take Control of the One Thing They Can

    AUSTIN, Texas, July 14, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced a new campaign partnership with Amanda Kloots, fitness entrepreneur, television host, and one of the most recognized voices on grief, resilience, and family in America. In a new national campaign, Kloots shares her own story to help families understand why life insurance matters and why, through Ethos, there is no reason to put it off. "Amanda's story is known to millions of people who watched her family go through the unimaginable in real time," said Prassath Leelakrishnan, Chief Growth Officer at Ethos. "W

    7/14/26 9:05:00 AM ET
    $LIFE
    Specialty Insurers
    Finance

    Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

    AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the second quarter of 2026, which ended June 30, 2026, following the close of U.S. financial markets on Monday, August 3, 2026. The company’s earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com. Ethos executives will host a conference call to discuss the results at 1:30 p.m. PT / 4:30 p.m. ET the same day. The live webcast of the conference call can be found on the Ethos Investor Relation

    7/2/26 4:35:00 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Ethos Technologies with a new price target

    Goldman initiated coverage of Ethos Technologies with a rating of Buy and set a new price target of $33.00

    2/23/26 8:37:19 AM ET
    $LIFE
    Specialty Insurers
    Finance

    Robert W. Baird initiated coverage on Ethos Technologies with a new price target

    Robert W. Baird initiated coverage of Ethos Technologies with a rating of Outperform and set a new price target of $18.00

    2/23/26 8:37:19 AM ET
    $LIFE
    Specialty Insurers
    Finance

    Citizens initiated coverage on Ethos Technologies with a new price target

    Citizens initiated coverage of Ethos Technologies with a rating of Mkt Outperform and set a new price target of $21.00

    2/23/26 8:36:59 AM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Wang Lingke was granted 900,000 shares, increasing direct ownership by 129% to 1,595,302 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    7/10/26 5:00:15 PM ET
    $LIFE
    Specialty Insurers
    Finance

    CEO and Secretary Colis Peter George was granted 900,000 shares, increasing direct ownership by 129% to 1,595,302 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    7/10/26 5:00:14 PM ET
    $LIFE
    Specialty Insurers
    Finance

    President Wang Lingke sold $1,024,561 worth of shares (46,349 units at $22.11), decreasing direct ownership by 14% to 695,302 units (SEC Form 4) (withholding tax)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    5/19/26 8:34:42 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Ethos Technologies Inc.

    SCHEDULE 13G - Ethos Technologies Inc. (0001788451) (Subject)

    5/15/26 9:00:02 PM ET
    $LIFE
    Specialty Insurers
    Finance

    SEC Form 144 filed by Ethos Technologies Inc.

    144 - Ethos Technologies Inc. (0001788451) (Subject)

    5/15/26 6:00:42 PM ET
    $LIFE
    Specialty Insurers
    Finance

    SEC Form 144 filed by Ethos Technologies Inc.

    144 - Ethos Technologies Inc. (0001788451) (Subject)

    5/15/26 5:59:47 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

    AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the appointment of William J. Wheeler to its Board of Directors. Mr. Wheeler, a seasoned executive with deep expertise across insurance, retirement services, and investment banking, joins Ethos' distinguished board, further strengthening Ethos' governance and strategic guidance as the company continues its rapid growth and innovation. Mr. Wheeler brings more than three decades of leadership experience in the financial services industry. He most recently served as Vice Chairman of Athene Holding Ltd. (NYSE:ATH), a leadin

    7/30/25 11:00:00 AM ET
    $EVR
    $LIFE
    $ATH
    Investment Managers
    Finance
    Specialty Insurers
    Life Insurance

    aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor

    SAN DIEGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (NASDAQ:LIFE) (aTyr or "the Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the appointment of Wayne A. I. Frederick, M.D., as an advisor to the company. Dr. Frederick is President Emeritus of Howard University, having served as President from 2014 to 2023. "We are honored to welcome a distinguished physician executive such as Dr. Frederick as an advisor to aTyr," said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr. "Dr. Frederick's clinical background combined with

    1/18/24 8:00:00 AM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Financials

    Live finance-specific insights

    View All

    Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

    AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the second quarter of 2026, which ended June 30, 2026, following the close of U.S. financial markets on Monday, August 3, 2026. The company’s earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com. Ethos executives will host a conference call to discuss the results at 1:30 p.m. PT / 4:30 p.m. ET the same day. The live webcast of the conference call can be found on the Ethos Investor Relation

    7/2/26 4:35:00 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

    AUSTIN, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the first quarter of 2026, which ended March 31, 2026, following the close of U.S. financial markets on Wednesday, May 6, 2026. The company's earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com. Ethos executives will host a conference call to discuss the results at 1:30 p.m. PT / 4:30 p.m. ET the same day. The live webcast of the conference call can be found on the Ethos Investor Relatio

    4/2/26 4:05:00 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    Records full-year revenue of $387.6 million, growing 52% year-over-yearAchieves Net Income of $24.6 million and Adjusted EBITDA of $25.8 million in Q4, reflecting a 22% margin and a 23% Adjusted EBITDA marginDelivers third consecutive year of revenue growth greater than 50% AUSTIN, Texas, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. "We delivered a strong close to 2025 with 65% year-over-year revenue growth in Q4," said Peter Colis, CEO and Co-Founder of Ethos. "Our financial resul

    2/25/26 4:05:00 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $LIFE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by aTyr Pharma Inc. (Amendment)

    SC 13G/A - aTYR PHARMA INC (0001339970) (Subject)

    2/14/24 1:43:55 PM ET
    $LIFE
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by aTyr Pharma Inc. (Amendment)

    SC 13G/A - aTYR PHARMA INC (0001339970) (Subject)

    2/13/24 4:30:17 PM ET
    $LIFE
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by aTyr Pharma Inc. (Amendment)

    SC 13G/A - aTYR PHARMA INC (0001339970) (Subject)

    2/9/24 8:35:54 AM ET
    $LIFE
    Specialty Insurers
    Finance